# TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV

> **NCT01674738** · PHASE2 · WITHDRAWN · sponsor: **Aktion Bronchialkarzinom e.V.**

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01674738
- **Lead sponsor:** Aktion Bronchialkarzinom e.V.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decision of the Sponsor, as the funding of the study was no longer guaranteed.
- **Last updated:** 2013-10-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674738, "TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01674738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*